155 related articles for article (PubMed ID: 36860671)
1. S100A11 Promotes Metastasis via AKT and ERK Signaling Pathways and Has a Diagnostic Role in Hepatocellular Carcinoma.
Zheng M; Meng H; Li Y; Shi J; Han Y; Zhao C; Chen J; Han J; Liang J; Chen Y; Liu Q; Wang Y
Int J Med Sci; 2023; 20(3):318-328. PubMed ID: 36860671
[TBL] [Abstract][Full Text] [Related]
2. EGFRvIII mediates hepatocellular carcinoma cell invasion by promoting S100 calcium binding protein A11 expression.
Luo X; Xie H; Long X; Zhou M; Xu Z; Shi B; Jiang H; Li Z
PLoS One; 2013; 8(12):e83332. PubMed ID: 24376686
[TBL] [Abstract][Full Text] [Related]
3. The S100 calcium-binding protein A11 promotes hepatic steatosis through RAGE-mediated AKT-mTOR signaling.
Teng F; Jiang J; Zhang J; Yuan Y; Li K; Zhou B; Zhou X; Liu W; Zhang P; Liu D; Zheng M; Lu Y; Zhang H
Metabolism; 2021 Apr; 117():154725. PubMed ID: 33571540
[TBL] [Abstract][Full Text] [Related]
4. HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK/ERK and PI3K/AKT signaling pathways.
Li Q; Wang C; Wang Y; Sun L; Liu Z; Wang L; Song T; Yao Y; Liu Q; Tu K
J Exp Clin Cancer Res; 2018 Sep; 37(1):231. PubMed ID: 30231922
[TBL] [Abstract][Full Text] [Related]
5. High-metastatic cancer cells derived exosomal miR92a-3p promotes epithelial-mesenchymal transition and metastasis of low-metastatic cancer cells by regulating PTEN/Akt pathway in hepatocellular carcinoma.
Yang B; Feng X; Liu H; Tong R; Wu J; Li C; Yu H; Chen Y; Cheng Q; Chen J; Cai X; Wu W; Lu Y; Hu J; Liang K; Lv Z; Wu J; Zheng S
Oncogene; 2020 Oct; 39(42):6529-6543. PubMed ID: 32917956
[TBL] [Abstract][Full Text] [Related]
6. PRMT9 promotes hepatocellular carcinoma invasion and metastasis via activating PI3K/Akt/GSK-3β/Snail signaling.
Jiang H; Zhou Z; Jin S; Xu K; Zhang H; Xu J; Sun Q; Wang J; Xu J
Cancer Sci; 2018 May; 109(5):1414-1427. PubMed ID: 29603830
[TBL] [Abstract][Full Text] [Related]
7. S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-κB-dependent MMP-9 signal.
Zhang J; Zhang DL; Jiao XL; Dong Q
Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2372-82. PubMed ID: 24065232
[TBL] [Abstract][Full Text] [Related]
8. Carboxypeptidase A6 Promotes the Proliferation and Migration of Hepatocellular Carcinoma by Up-regulating AKT Signaling Pathway.
Huang QB; Zhang HW; Liao ZB
Curr Med Sci; 2019 Oct; 39(5):727-733. PubMed ID: 31612389
[TBL] [Abstract][Full Text] [Related]
9. FAM134B induces tumorigenesis and epithelial-to-mesenchymal transition via Akt signaling in hepatocellular carcinoma.
Zhang ZQ; Chen J; Huang WQ; Ning D; Liu QM; Wang C; Zhang L; Ren L; Chu L; Liang HF; Fan HN; Zhang BX; Chen XP
Mol Oncol; 2019 Apr; 13(4):792-810. PubMed ID: 30556279
[TBL] [Abstract][Full Text] [Related]
10. S100A11 regulates renal carcinoma cell proliferation, invasion, and migration via the EGFR/Akt signaling pathway and E-cadherin.
Liu L; Miao L; Liu Y; Qi A; Xie P; Chen J; Zhu H
Tumour Biol; 2017 May; 39(5):1010428317705337. PubMed ID: 28513300
[TBL] [Abstract][Full Text] [Related]
11. LINC00707 promotes hepatocellular carcinoma progression through activating ERK/JNK/AKT pathway signaling pathway.
Wang J; Luo Z; Yao T; Li W; Pu J
J Cell Physiol; 2019 May; 234(5):6908-6916. PubMed ID: 30317590
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of LncRNA NR027113 inhibits cell proliferation and metastasis via PTEN/PI3K/AKT signaling pathway in hepatocellular carcinoma.
Chen Z; Zhou ZY; He CC; Zhang JL; Wang J; Xiao ZY
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7222-7232. PubMed ID: 30468465
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-8 Induces Expression of FOXC1 to Promote Transactivation of CXCR1 and CCL2 in Hepatocellular Carcinoma Cell Lines and Formation of Metastases in Mice.
Huang W; Chen Z; Zhang L; Tian D; Wang D; Fan D; Wu K; Xia L
Gastroenterology; 2015 Oct; 149(4):1053-67.e14. PubMed ID: 26065367
[TBL] [Abstract][Full Text] [Related]
14. SIX4 promotes hepatocellular carcinoma metastasis through upregulating YAP1 and c-MET.
He Q; Lin Z; Wang Z; Huang W; Tian D; Liu M; Xia L
Oncogene; 2020 Dec; 39(50):7279-7295. PubMed ID: 33046796
[TBL] [Abstract][Full Text] [Related]
15. KIFC1 regulated by miR-532-3p promotes epithelial-to-mesenchymal transition and metastasis of hepatocellular carcinoma via gankyrin/AKT signaling.
Han J; Wang F; Lan Y; Wang J; Nie C; Liang Y; Song R; Zheng T; Pan S; Pei T; Xie C; Yang G; Liu X; Zhu M; Wang Y; Liu Y; Meng F; Cui Y; Zhang B; Liu Y; Meng X; Zhang J; Liu L
Oncogene; 2019 Jan; 38(3):406-420. PubMed ID: 30115976
[TBL] [Abstract][Full Text] [Related]
16. Bromodomain-containing protein 9 promotes the growth and metastasis of human hepatocellular carcinoma by activating the TUFT1/AKT pathway.
Dou C; Sun L; Wang L; Cheng J; Wu W; Zhang C; Xu Q; Tu K; Liu J
Cell Death Dis; 2020 Sep; 11(9):730. PubMed ID: 32908135
[TBL] [Abstract][Full Text] [Related]
17. TFAP4 Promotes Hepatocellular Carcinoma Invasion and Metastasis via Activating the PI3K/AKT Signaling Pathway.
Huang T; Chen QF; Chang BY; Shen LJ; Li W; Wu PH; Fan WJ
Dis Markers; 2019; 2019():7129214. PubMed ID: 31281549
[TBL] [Abstract][Full Text] [Related]
18. CADM2, as a new target of miR-10b, promotes tumor metastasis through FAK/AKT pathway in hepatocellular carcinoma.
Li D; Zhang Y; Zhang H; Zhan C; Li X; Ba T; Qiu Z; E F; Lv G; Zou C; Wang C; Si L; Zou C; Li Q; Gao X
J Exp Clin Cancer Res; 2018 Mar; 37(1):46. PubMed ID: 29506532
[TBL] [Abstract][Full Text] [Related]
19. Correlation of LAGE3 with unfavorable prognosis and promoting tumor development in HCC via PI3K/AKT/mTOR and Ras/RAF/MAPK pathways.
Li Y; Xiong H
BMC Cancer; 2022 Mar; 22(1):298. PubMed ID: 35313850
[TBL] [Abstract][Full Text] [Related]
20. PRMT4 promotes hepatocellular carcinoma progression by activating AKT/mTOR signaling and indicates poor prognosis.
Du P; Luo K; Li G; Zhu J; Xiao Q; Li Y; Zhang X
Int J Med Sci; 2021; 18(15):3588-3598. PubMed ID: 34522186
[No Abstract] [Full Text] [Related]
[Next] [New Search]
